Abstract: In a network system (1), in response to a user's operation on a video telephone (32) having no browser function, WEB data described in HTML is supplied from a WEB server (26) to a WEB browse server (4) by HTTP. The supplied WEB data is converted by the WEB browse server (4), for example, into dynamic image data in the MPEG format which can be displayed on the video telephone (32). Furthermore, the dynamic image data is distributed via a transmission path set between the WEB browse server (4) and the video telephone (32) by line switching to the video telephone (32) so as to be displayed. That is, in the network system (1), a user of the video telephone (32) having a dynamic image display function and an audio transmission function but no browser function can view a WEB image on the Internet.

Abstract: An object of the present invention is to provide a data distribution system which is suitable to distribute data to a mobile terminal device and the like to cause the mobile terminal device and the like to display an image, and a method therefor. In response to a request from a mobile communication device (2) through a web page distribution server (5), a web server (12) distributes document data shown in FIG. 2 to the web page distribution server (5). The web page distribution server (5) creates an image of the distributed document data, and divides the created image into a plurality of areas to thereby create divided area data. In response to the request from the mobile communication device (2), the webpage distribution server (5) sequentially distributes such components of the created divided area data as are to be actually displayed, to the mobile communication device (2). The mobile communication device (2) sequentially displays the divided area data distributed from the web page distribution server (5).

Abstract: In a network system (1), in response to a user's operation on a video telephone (32) having no browser function, WEB data described in HTML is supplied from a WEB server (26) to a WEB browse server (4) by HTTP. The supplied WEB data is converted by the WEB browse server (4), for example, into dynamic image data in the MPEG format which can be displayed on the video telephone (32). Furthermore, the dynamic image data is distributed via a transmission path set between the WEB browse server (4) and the video telephone (32) by line switching to the video telephone (32) so as to be displayed. That is, in the network system (1), a user of the video telephone (32) having a dynamic image display function and an audio transmission function but no browser function can view a WEB image on the Internet.

Abstract: An improved system and method for data transmission is provided without changing the configuration of a client. A data-reading server (2) receives an e-mail including a URL from an e-mail client (6), extracts the URL from the e-mail, and accesses a Web server (4) via an internal network (160) to receive. Web data. The data-reading server (2) composes an e-mail by converting the received data into data in an MIME format and transmits the e-mail to the e-mail client (6). The user of the e-mail client (6) can read the Web page in an intranet from outside the intranet through an e-mail browser.

Abstract: An object of the present invention is to provide a data distribution system which is suitable to distribute data to a mobile terminal device and the like to cause the mobile terminal device and the like to display an image, and a method therefor. In response to a request from a mobile communication device (2) through a web page distribution server (5), a web server (12) distributes document data shown in FIG. 2 to the web page distribution server (5). The web page distribution server (5) creates an image of the distributed document data, and divides the created image into a plurality of areas to thereby create divided area data. In response to the request from the mobile communication device (2), the webpage distribution server (5) sequentially distributes such components of the created divided area data as are to be actually displayed, to the mobile communication device (2). The mobile communication device (2) sequentially displays the divided area data distributed from the web page distribution server (5).

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) effective against diseases in which histamine, leukotrienes, etc. participate and effective in preventing or treating diseases in which chemical mediators such as histamine and leukotrienes participate, for example, asthma, allergic rhinitis, atopic dermatitis, urticaria, hay fever, gastrointestinal allergy and food allergy.

Abstract: Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a —CONH— group or a group represented by the formula —CR6═CR7— in which R6 and R7 represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) 1

Abstract: Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): 1

Abstract: Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a —CONH— group or a group represented by the formula —CR6═CR7— in which R6 and R7 represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) effective against diseases in which histamine, leukotrienes, etc. participate and effective in preventing or treating diseases in which chemical mediators such as histamine and leukotrienes participate, for example, asthma, allergic rhinitis, atopic dermatitis, urticaria, hay fever, gastrointestinal allergy and food allergy.

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) 1

Abstract: Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): 1

Abstract: The present invention provides a medicament exhibiting excellent retinoic acid receptor agonism. A Carboxylic acid derivative having a fused ring which is represented by the following formula or a pharmacologically acceptable salt thereof: {wherein the symbol represents a single bond or a double bond; X, Y, Z, P, Q, U, V and W are each a group represented by the formula: —O— or —S—, or a group represented by the formula: [wherein Rk (k: 1 to 8) is hydrogen, halogeno, optionally substituted lower alkyl or the like, with either of R7 and R8 being a group represented by the formula: (wherein A and B are each independently an optionally substituted aromatic hydrocarbon ring or an optionally substituted unsaturated heterocycle; and D is optionally protected carboxyl)]}.

Abstract: Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): 1

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) effective against diseases in which histamine, leukotrienes, etc. participate and effective in preventing or treating diseases in which chemical mediators such as histamine and leukotrienes participate, for example, asthma, allergic rhinitis, atopic dermatitis, urticaria, hay fever, gastrointestinal allergy and food allergy.

Abstract: Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a —CONH— group or a group represented by the formula —CR6═CR7— in which R6 and R7 represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

Abstract: The present invention provides a medicament exhibiting excellent retinoic acid receptor agonism.A Carboxylic acid derivative having a fused ring which is represented by the following formula or a pharmacologically acceptable salt thereof: ##STR1## {wherein the symbol ----- represents a single bond or a double bond; X, Y, Z, P, Q, U, V and W are each a group represented by the formula: --O-- or --S--, or a group represented by the formula: ##STR2## [wherein R.sup.k (k:1 to 8) is hydrogen, halogeno, optionally substituted lower alkyl or the like, with either of R.sup.7 and R.sup.8 being a group represented by the formula: ##STR3## (wherein A and B are each independently an optionally substituted aromatic hydrocarbon ring or an optionally substituted unsaturated heterocycle; and D is optionally protected carboxyl)]}.

Abstract: The present invention provides a medicament exhibiting excellent retinoic acid receptor agonism.A Carboxylic acid derivative having a fused ring which is represented by the following formula or a pharmacologically acceptable salt thereof: ##STR1## {wherein the symbol ##STR2## represents a single bond or a double bond; X, Y, Z, P, Q, U, V and W are each a group represented by the formula: --O-- or --S--, or a group represented by the formula: ##STR3## [wherein R.sup.k (k: 1 to 8) is hydrogen, halogeno, optionally substituted lower alkyl or the like, with either of R.sup.7 and R.sup.8 being a group represented by the formula: ##STR4## (wherein A and B are each independently an optionally substituted aromatic hydrocarbon ring or an optionally substituted unsaturated heterocycle; and D is optionally protected carboxyl)]}.

Abstract: The present invention relates to a substituted thiazolo[3,2-a] azepine derivative having inhibitory activity against angiotensin I converting enzyme and neutral endpeptidase and is represented by the following general formula (I): ##STR1##